Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Announces Execution of Final Settlement Agreement and Release Resolving "Track 1" Opioid Cases

Canada NewsWire September 5, 2019

Endo to Present New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand's (ASSH) Annual Meeting

PR Newswire September 5, 2019

Endo Announces Approval of First Generic Orfadin® in U.S.

PR Newswire September 4, 2019

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Delayed-release Tablets in the United States

Canada NewsWire September 3, 2019

Football Legend John Elway Reveals He has Dupuytren's Contracture and Wants Others to Get the "Facts on Hand"

Canada NewsWire August 22, 2019

Endo Announces Settlement in Principle to Resolve "Track 1" Opioid Cases

Canada NewsWire August 20, 2019

Endo Reports Second-Quarter 2019 Financial Results

Canada NewsWire August 5, 2019

Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities

Canada NewsWire August 2, 2019

Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics

Canada NewsWire August 1, 2019

Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada

Canada NewsWire July 31, 2019

Endo to Announce Second-Quarter 2019 Financial Results

Canada NewsWire July 11, 2019

Nevakar Enters $50 Million Product Financing Agreement with NovaQuest Capital for Continued Development of Injectable Products

GlobeNewswire June 18, 2019

Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month

Canada NewsWire June 6, 2019

Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019

Canada NewsWire May 17, 2019

Endo to Participate at RBC Healthcare Conference

Canada NewsWire May 15, 2019

Endo Reports First-Quarter 2019 Financial Results

Canada NewsWire May 9, 2019

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product

Canada NewsWire May 1, 2019

Endo to Announce First-Quarter 2019 Financial Results

PR Newswire Europe Non Regulatory April 10, 2019

Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States

PR Newswire Europe Non Regulatory April 5, 2019

Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes

PR Newswire March 27, 2019